Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials.
Low Confidence Trial DesignPrimary source: [Open]
Linked compounds: retatrutide
Outcomes summary
Rationale and design paper describing the Phase 3 TRIUMPH registrational program for retatrutide across weight management, obstructive sleep apnea, and knee osteoarthritis, including endpoints and estimands.
Limitations
Design/rationale publication; does not report efficacy or safety outcomes. Use for understanding trial structure and endpoints, not for effect estimates.
Notes
Primary source: PMID 41090431.